Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCamellia Regulatory News (CAM)

Share Price Information for Camellia (CAM)

Share Price is delayed by 15 minutes
Get Live Data
5,500.00    75.00 (1.38%)
Bid:
5,400.00
Ask:
5,600.00
Spread: 200.00 (3.704%)
Market Cap: £137.13m
CAM Live PriceLast checked at - London Stock Exchange

Intraday Camellia Share Chart

Update on African allegations

8 Oct 2020 17:15

RNS Number : 5632B
Camellia PLC
08 October 2020
Β 

8 October 2020

Camellia Plc (the "Company")

Update on allegations relating to African operationsΒ 

Β 

As stated in January 2020 and most recently in the interim report in September, Camellia and a number of its subsidiary companies have been put on notice of claims relating to allegations against two companies in its African operations.Β One of these is Kakuzi Plc in whichΒ Camellia bought a controlling stake (50.7%) in the mid-1990s. Kakuzi Plc is quoted on the Nairobi Securities Exchange and is managed by its Board of Directors on behalf of its 1,300 mostly Kenyan shareholders.

Camellia takes any complaint of criminality, misconduct, illegality, or unethical behaviour against its operations very seriously. The allegations are of serious assault, harassment and sexual misconduct allegedly committed by certain individuals apparently employed by the two foreign operating companies. The allegations are being investigated by the two African companies but they are beingΒ hindered by UK lawyers Leigh Day's insistence on anonymity.

The two African companies have recognised alternative dispute resolution ("ADR") mechanisms locally so that any allegations are properly examined. If there has been any wrongdoing those responsible will be held to account, and if shortcomings are identified the companies will improve their safeguarding processes and victims will be compensated.Β Complainants can access independent legal advice, the costs of which will be borne by the operating companies, including if claims fail.

The cost of this ADR process will be expensed in 2020 and in the future and will be in addition to the Β£4.8m of legal and related costs incurred in 2019 and up to 30 June 2020 as previously disclosed.

Β 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

Enquiries

Camellia Plc 01622 746655

Tom Franks, CEO

Susan Walker, CFO

Β 

Panmure Gordon 020 7886 2500

Nominated Adviser and Broker

Emma Earl

Erik Anderson

Β 

Maitland/AMO

PR

William Clutterbuck 07785 292617

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
UPDKKFBPPBDDCKK
Date   Source Headline
4th Jun 202612:31 pmRNSResult of AGM
22nd May 20267:00 amRNSSale of Chalouni Tea Estate
5th May 20267:00 amRNSFinal Results
7th Apr 20264:19 pmRNSProposed Sale of Chalouni Tea Estate
1st Apr 20267:00 amRNSArtwork Sale and Update on Indian Tea Estate MOU
23rd Feb 20267:00 amRNSTrading Update
23rd Jan 20267:00 amRNSDirectorate change
27th Nov 20257:00 amRNSKakuzi Land Claims
8th Sep 20254:47 pmRNSDirector/PDMR Shareholding
5th Sep 20257:00 amRNSHalf Year Results
26th Aug 20257:00 amRNSNotice of Half Year Results
4th Jul 20254:30 pmRNSDisposal
13th Jun 20254:01 pmRNSHolding(s) in Company
13th Jun 20252:35 pmRNSHolding(s) in Company
10th Jun 20259:09 amRNSHolding(s) in Company
9th Jun 20254:39 pmRNSHolding(s) in Company 9 June 2025
6th Jun 20257:00 amRNSResult of Tender Offer
5th Jun 20252:02 pmRNSResult of General Meetings
19th May 20257:00 amRNSTender Offer
19th May 20257:00 amRNSValue Enhancement Plan
13th May 20257:00 amRNSHolding(s) in Company
9th May 20257:00 amRNSTransaction in Own Shares
8th May 20257:00 amRNSValue Enhancement Plan Date & Presentation
30th Apr 20257:00 amRNSFinal Results
28th Apr 20257:00 amRNSTransaction in Own Shares
25th Apr 20257:00 amRNSTransaction in Own Shares
24th Apr 20257:00 amRNSTransaction in Own Shares
23rd Apr 20257:00 amRNSTransaction in Own Shares
22nd Apr 20257:00 amRNSTransaction in Own Shares
17th Apr 20257:00 amRNSPotential Disposal
15th Apr 20257:00 amRNSTransaction in Own Shares
14th Apr 20257:00 amRNSTransaction in Own Shares
9th Apr 20257:00 amRNSTransaction in Own Shares
8th Apr 20257:00 amRNSTransaction in Own Shares
7th Apr 20259:07 amRNSTransaction in Own Shares
20th Mar 20257:00 amRNSTransaction in Own Shares
17th Mar 20257:00 amRNSTransaction in Own Shares
13th Mar 20257:00 amRNSDisposal
11th Mar 20257:00 amRNSTransaction in Own Shares
5th Mar 20257:00 amRNSTransaction in Own Shares
4th Mar 20257:00 amRNSTransaction in Own Shares
26th Feb 20257:00 amRNSTransaction in Own Shares
25th Feb 20257:00 amRNSTransaction in Own Shares
20th Feb 20257:00 amRNSTransaction in Own Shares
17th Feb 20257:00 amRNSTransaction in Own Shares
12th Feb 20257:00 amRNSPotential Disposal
11th Feb 20257:00 amRNSTransaction in Own Shares
10th Feb 20257:00 amRNSTransaction in Own Shares
7th Feb 20257:00 amRNSTransaction in Own Shares
6th Feb 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.